NLARx Newsletter Header
NLARx News
July 16, 2008
In This Issue
NLARX in the News
See you at NCSL
In the States
Prices & Health Costs
Fraud & Abuse
Generics & Patents
Conflicts of Interest
Pharma Watch
Advertising & Marketing
Medicare & Medicaid
Medicaid
Safety & Clinical Trials
Electronic Records
FDA Watch
Trade and Health
Quick Links
Join Our Mailing List
NLARx News
State Legislators Call New PhRMA Ethics Code "Baby Step" More
NLARx Executive Director Treat Interviewed on PhRMA Code on NPR's "Marketplace" More
... and in NY Times article More
... and presents at 340B conference on State Policy Options - 340B Challenges and Opportunities More
NLARx Workshop at NCSL Annual Conference
A Shot in the Arm: New Lessons in the Battle to Save Drug Costs and Protect Patients. New Orleans, LA.
July 25, 2008. More
In the States
WEST VIRGINIA: Manchin Seeks More Detailed Drug Disclosure More
Pharma Ads Top $16M in 6 Months More
Report on the Legislative Rule on Prescription Drug Advertising Expense Reporting More
DISTRICT OF COLUMBIA: Drug Representative Regulations Proposed More
TEXAS: Attorney General Sues Generic Makers Over Medicaid Fraud More
MASSACHUSETTS: Governor Proposes Contributing More to State's Health Insurance Law More
VERMONT: Drug Companies Spend More in Vermont in 2007, Says AG More
State Pushes Protection of Patient Drug Info More
Prices & Health Costs
Costly Cancer Drug Offers Hope, Dilemma More
Costly Cancer Drugs Affect Physicians' Treatment Decisions More
Financing the U.S. Health System - Issues and Options for Change More
Fraud & Abuse
Over 500 Backlogged Whistle-Blower Cases Allege Fraud More
Medicare Dead-Doctor Billing Scams; False Claims Could Top $100M More
Private-Label Drugmaker Pays $10M Fraud Fine More
U.S. Seeks Ranbaxy Documents More
Judge Urges Lilly To Settle Zyprexa Lawsuits More
GSK, Novartis to Appeal Judgment in Alabama Drug Price Suit  More
Medicare Audit Recovery Program Has Recovered $700M in Overpayments to Providers More
CMS Official Says New System Will Prevent Fraudulent Medicare Claims From Using Dead Doctors' Names More
Transkaryotic Ex-Executive Will Pay to Settle With SEC More
Generics & Patent Policy
Roche Seeks US Compulsory License for Anemia Drug More
Effort for Lower Drug Prices Would Focus on Gaining Patents More
CBO Estimates $25 Billion Savings with Biogeneric Pathway More
India Lets Pharma Challenge Compulsory Licenses More
Conflicts of Interest
PhRMA Announces Revised Voluntary Gift Guidelines More
Sen. Grassley Asks Psychiatry Association To Provide Information on Drug Industry Contributions More
NIH Fails to Oversee Grantees' Conflicts of Interest, Grassley Says More
Blood-Study Author Didn't Disclose Conflicts More
VT Attorney General Publishes List of Doctors' Gifts from Pharma - Is Your Doctor in the Top 100? More
Pharma Watch
Glaxo Seeks Guidance From Health Systems More
Cardinal Cuts 600 Jobs More
Merck, Eli Lilly and Pfizer Form Joint Venture to Create New Drug-Discovery Methods and Cut Costs More
Large Drug Companies Lack Innovation, Letter in WSJ States More
Pfizer To Cut 275 Jobs From Michigan Plant More
Boehringer Ingelheim Cutting Neuro Sales Reps More
Glaxo May Pay Eye-Opening $3.3B For Sleeping Pill More
Advertising & Marketing
More on PhRMA Revised Marketing Code More
Prescription Project Statement on PhRMA's Revised Code on Marketing More
Drug Industry to Announce Revised Code More
Manchin Seeks More Detailed Marketing Disclosure More
PhRMA Releases Revised "Code on Interactions with Healthcare Professionals" that is More Restrictive than the July 2002 Version More
Ban on Free Meals for Elderly Opposed by a Medicare Marketer More
Pharma Ads Top $16M in 6 Months More
Disease Mongering Reaches New Low with Statin Drug Push For 8-Year-Olds More
Cholesterol Screening Is Urged for Young More
AAP Guidelines May Help Extend the Patent Life of Lipitor More
Medicare
Bush Vetoes Measure Blocking Medicare Doctor Fee Cuts More
Bush to Veto Bill Restoring Medicare Doctors' Pay More
Senate Votes 69-30 To Approve Legislation That Would Halt Medicare Physician Payment Cut More
Bill Passes that Protects Community Pharmacy Access More
Medicaid
New AARP Report Finds Older Americans Have Limited Access to Home and Community-Based Services Under Medicaid More
Bristol-Myers Squibb to Pay Mass. Medicaid Program $9.2M to Settle Claims More
Safety & Clinical Trials
FDA to Team With Australia, EU for Overseas Inspections More
Judge Overturns Award in Wyeth Suit More
Actavis Sued Over Digitek Heart Drug More
Teva Is Being Investigated Over Copaxone Trial More
FDA to Add Warning to Antibiotics More
Drugs' Links To Suicide Risk Draw Concern More
Web Sites Still Offer Controlled  Substances Without Prescription More
Epilepsy Drugs May Avoid Black Box More
The Great Drug Debate More
Study: Popular Prescription Drugs Raise Seniors' Fall Risk  More
Electronic Records
DEA Proposes E-Prescribing Regs More
NEJM Perspective Examines Increasing Use of E-Prescribing in U.S. More
FDA Watch
As Agency Struggles, FDA Execs Reap Lavish Bonuses More
Trade and Health
PhRMA Comments on the Proposed Anti-Counterfeiting Trade Agreement More